Add to ORKGObjectives: Major guidelines regarding the application of cost-effectiveness analysis (CEA) have recommended the common and wide-spread use of the “societal perspective ” for purposes of consistency and comparability. The objective of this Task Force subgroup report (one of six reports from the International Society for Pharmacoeconomics and Out
AbstractObjectivesThe objective of this report is to provide guidance and recommendations on how dru...
AbstractObjectivesThe industry perspective on drug costs should be framed by the need for decision-m...
AbstractObjectivesPublic programs finance a large share of the US pharmaceutical expenditures. To da...
Objectives: Major guidelines regarding the application of cost-effectiveness analysis (CEA) have rec...
AbstractObjectivesMajor guidelines regarding the application of cost-effectiveness analysis (CEA) ha...
the state-of-the-art in cost-effectiveness analysis (CEA). To improve comparability an
AbstractObjectivesThe assignment of prices or costs to pharmaceuticals can be crucial to results and...
Objective: The pharmacoeconomic guidelines available in the literature or promulgated in many countr...
Objective: The pharmacoeconomic guidelines available in the literature or promulgated in many countr...
Objectives: The assignment of prices or costs to pharmaceuticals can be crucial to results and concl...
AbstractObjectiveThe pharmacoeconomic guidelines available in the literature or promulgated in many ...
Objectives: The objective of this report is to provide guidance and rec-ommendations on how drug cos...
AbstractObjectivesThe industry perspective on drug costs should be framed by the need for decision-m...
AbstractObjectivesThe assignment of prices or costs to pharmaceuticals can be crucial to results and...
AbstractObjectiveThe pharmacoeconomic guidelines available in the literature or promulgated in many ...
AbstractObjectivesThe objective of this report is to provide guidance and recommendations on how dru...
AbstractObjectivesThe industry perspective on drug costs should be framed by the need for decision-m...
AbstractObjectivesPublic programs finance a large share of the US pharmaceutical expenditures. To da...
Objectives: Major guidelines regarding the application of cost-effectiveness analysis (CEA) have rec...
AbstractObjectivesMajor guidelines regarding the application of cost-effectiveness analysis (CEA) ha...
the state-of-the-art in cost-effectiveness analysis (CEA). To improve comparability an
AbstractObjectivesThe assignment of prices or costs to pharmaceuticals can be crucial to results and...
Objective: The pharmacoeconomic guidelines available in the literature or promulgated in many countr...
Objective: The pharmacoeconomic guidelines available in the literature or promulgated in many countr...
Objectives: The assignment of prices or costs to pharmaceuticals can be crucial to results and concl...
AbstractObjectiveThe pharmacoeconomic guidelines available in the literature or promulgated in many ...
Objectives: The objective of this report is to provide guidance and rec-ommendations on how drug cos...
AbstractObjectivesThe industry perspective on drug costs should be framed by the need for decision-m...
AbstractObjectivesThe assignment of prices or costs to pharmaceuticals can be crucial to results and...
AbstractObjectiveThe pharmacoeconomic guidelines available in the literature or promulgated in many ...
AbstractObjectivesThe objective of this report is to provide guidance and recommendations on how dru...
AbstractObjectivesThe industry perspective on drug costs should be framed by the need for decision-m...
AbstractObjectivesPublic programs finance a large share of the US pharmaceutical expenditures. To da...